Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas

Pituitary

Volumn 11, Issue 1, 2008, Pages 37-48

  Gong, Jian ^a   Zhao, Yunge ^a   Abdel Fattah, Rana ^a   Amos, Samson ^a   Xiao, Aizhen ^a   Lopes, M Beatriz S ^a   Hussaini, Isa S ^a   Laws, Edward R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Biological marker; Invasion; Matrix metalloproteinase; Noninvasion; Pituitary tumor

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; MESSENGER RNA;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; STATISTICAL ANALYSIS; STUDENT T TEST; TUMOR CLASSIFICATION; TUMOR VOLUME; WESTERN BLOTTING; ZYMOGRAPHY;

ADENOMA; ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CHILD; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 38649089803     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0066-2     Document Type: Article

References (47)

1. Selman WR, Laws ER, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402-407
2. Meiji BP, Lopes MS, Ellegala DB, Alden T, Laws ER (2002) The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96:195-208
3. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610-618 (Laws ER comment)
4. Isono M, Inoue R, Kamida T, Kobayashi H, Matsuyama J (2003) Significance of leptin expression in invasive potential of pituitary adenomas. Clin Neurol Neurosurg 105:111-116
5. Trouillas J, Daniel L, Guigard MP, Tong S, Gouvernet J, Jouanneau E, Jan M, Perrin G, Fischer G, Tabarin A, Rougon G, Figarella-Branger D (2003) Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. J Neurosurg 98:1084-1093
6. Kong YG, Su CB, Ren ZY, Wang RZ, Li GL, Dou WC, Zhang B, Tian SQ (2003) Measurement of soluble CD44v6 in peripheral blood as assistant diagnosis of invasive pituitary adenomas. [Article in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25:698-701
7. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER (1996) p53 expression in pituitary adenomas and carcinomas: Correlation with invasiveness and tumor growth fractions. Neurosurgery 38(4):765-771
8. Takino H, Herman V, Weiss M, Melmed S (1995) Purine-binding factor (nm23) gene expression in pituitary tumors: Marker of adenoma invasiveness. J Clin Endocrinol Metab 80:1733-1738
9. Amar AP, DeArmond SJ, Spencer DR, Coopersmith PF, Ramos DM, Rosenblum ML (1994) Development of an in vitro extracellular matrix assay for studies of brain tumor invasion. J Neuro-onc 20:1-15
10. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nature Rev 2:163-176
11. Werner JA, Rathcke IO, Mandic R et al (2002) The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19:275-282
12. Horikawa T, Yoshizaki T, Sheen TS et al (2000) Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89:715-723
13. Ballin M, Comez SE, Sinha CC, Thorgeirsson UP (1988) Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154:823-838
14. Bernhard ED, Gruber SB, Muschel RJ (1994) Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91:4293-4297
15. Hua J, Muschel R (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56:5279-5284
16. Nakajima M, Welch D, Wynn D, Tsuruo Y, Nocolson G (1993) Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res 53:5802-5807
17. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y (1993) Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion. J Cell Sci 104:991-999
18. Zucker S, Lysik RM, Zarrabi MH, Moll U (1993) M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. CancerRes 53:140-146
19. Sang QXA (1998) Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8:171-177
20. Kawamoto H, Uozumi T, Arita K, Yano T, Hirohata T (1996) Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochir (Wien) 138:390-395
21. Laquerriere A, Yun J, Hemet JTJ, Tadie M (1993) Experimental evaluation of bilayered human collagen as a dural substitute. J Neurosurg 78:487-491
22. Zhao YG, Cao XM, Xiao AZ, Zhu C (1999) Expression of MMP-2, -9,TIMP-1, -2, -3 mRNA in rat uterus during estrous cycle. Dev Reprod Biol 8:1-10
23. Zhao YG, Xiao AZ, Newcomer RG, Park HI, Kang T, Chung LW, Swanson MG, Zhau HE, Kurhanewicz J, Sang QX (2003) Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 278:15056-15064
24. Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC (1998) Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43:432-439
25. Hansen LK, Molitch ME (1998) Postoperative radiotherapy for clinically nonfunctioning pituitary adenomas. Endocrinologist 8:71-78
26. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GKK, Lopes MBS, Laws ER (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170(1):356-365
27. Yokoyama S, Hirano H, Moroki K, Goto M, Imamura S, Kuratsu J (2001) Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 49(4):857-863 (Laws ER Comment)
28. Scheithauer BW, Kovacs KT, Laws ER Jr et al (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744
29. Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JAH (2000) Role of matrix metalloproteinase 9 in pituitary tumor. Behav J Clin Endocrinol Metab 85(8):2931-2935
30. Pan LX, Chen ZP, Liu YS, Zhao JH (2005) Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space. J Neuro-Oncol 74:71-76
31. Pereda MP, Ledda MF, Goldberg V, Chervi'n A, Carrizo G, Molina H, Muller A, Renner U, Podhajcer O, Gunter EA, Stalla UK (2000) High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells. J Clin Endocrinol Metab 85:263-269
32. Kawamoto H, Kawamoto K, Mizoue T, Uozumi T, Arita K, Kurisu K (1996) Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis. Acta Neurochir (Wien) 138(12):1442-1448
33. Beaulieu E, Kachra Z, Mousseau N, Delbecchi L, Hardy J, Béliveau R (1999) Matrix metalloproteinases and their inhibitors in human pituitary tumors. Neurosurgery 45(6):1432-1441
34. Li Z, Ren Y, Wu Q, Lin S, Liang Y, Liang H (2004) Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. Chin Med J 117(1):107-114
35. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y (1992) Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA 89:11789-11793
36. Scheithauer BW (1982) Surgical pathology of the pituitary and sellar region. In: Laws ER Jr, Randall RV, Kern EB et al (eds) Management of pituitary adenomas and related lesions with emphasis on transsphenoidal microsurgery. Appleton-Century-Crofts, New York, pp 129-218
37. Sautner D, Saeger W (1991) Invasiveness of pituitary adenomas. Pathol Res Pract 187:632-636
38. Kovacs K, Horvath E (1986) Adenomas with ACTH production. In Tumors of the pituitary gland. Armed Forces Institute of Pathology, Washington, pp 134-164
39. Bradley KJ, Wass JAH, Turner HE (2003) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol 58:59-64
40. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, Laws ER, Young WF (2000) Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47:723-730
41. Knappe UJ, Hagel C, Lisboa BW, Wilczak W, Ludecke DK, Saeger W (2003) Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. Acta Neuropathol 106:471-478
42. Knappe UJ, Ludecke DK (1996) Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir (Wien) 65(Suppl):31-34
43. Liu W, Matsumoto Y, Okada M, Miyake K, Kunishio K, Kawai N, Tamiya T, Nagao S (2005) Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. J Med Invest 52:151-158
44. Fahlbusch R, Buchfelder M (1988) Transsphenoidal surgery of parasellar pituitary adenoms. Acta Neurochir (Wien) 92:93-99
45. Scotti G, Yu CY, Dillon WP, Norman D, Colombo N, Newton TH, De Groot J, Wilson CB (1988) MR imaging of cavernous sinus involvement by pituitary adenomas. AJNR 9:657-664
46. Comtois R, Beauregard H, Somma M, Serri O, Aris JN, Hardy J (1991) The clinical and endocrine outcome to transsphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860-866
47. Lozonschi L, Sunamura M, Kobari M, Egawa S, Ding L, Matsuno S (1999) Controlling tumour angiogenesis and metastasis of C26 murine colon adenocarcinomaby a new matrix metalloproteinase inhibitor, KB-R7785, in two tumour models. Cancer Res 59:1252-1258